Centene Corp Gets a Buy from Jefferies

By Austin Angelo

In a report released yesterday, David Windley from Jefferies reiterated a Buy rating on Centene Corp (NYSE: CNC), with a price target of $79. The company’s shares closed yesterday at $71.17.

According to TipRanks.com, Windley is a top 100 analyst with an average return of 15.5% and a 72.4% success rate. Windley covers the Healthcare sector, focusing on stocks such as Quintiles Transnational, WellCare Health Plans, and PRA Health Sciences.

Currently, the analyst consensus on Centene Corp is Moderate Buy and the average price target is $77.63, representing a 9.1% upside.

In a report issued on April 5, Deutsche Bank also initiated coverage with a Buy rating on the stock with a $84 price target.

Centene Corp’s market cap is currently $12.13B and has a P/E ratio of 22.59. The company has a book value ratio of 2.0756.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs, including Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.